Identification of SLC2A3 as a prognostic indicator correlated with the NF-κB/EMT axis and immune response in head and neck squamous cell carcinoma

References

• Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. Ca A Cancer J Clinicians. 2015 Mar;65(2):87–19.
   PubMed Web of Science ®Google Scholar
• Yan K, Agrawal N, Gooi Z. Head and neck masses. Med Clin North Am. 2018 Nov;102(6):1013–1025.
   PubMed Web of Science ®Google Scholar
• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: gLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Ca A Cancer J Clinicians. 2021 May;71(3):209–249.
   PubMed Web of Science ®Google Scholar
• Miller KD, Siegel RL, Lin CC, et al. Cancer treatment and survivorship statistics, 2016. Ca A Cancer J Clinicians. 2016 Jul;66(4):271–289.
   PubMed Web of Science ®Google Scholar
• Sun X, Li Z, Niu Y, et al. Jarid1b promotes epidermal differentiation by mediating the repression of Ship1 and activation of the AKT/Ovol1 pathway. Cell Prolif. 2019 Sep;52(5):e12638.
   PubMed Web of Science ®Google Scholar
• Zhang J, Fu H, Xu Y, et al. Hyperoside reduces albuminuria in diabetic nephropathy at the early stage through ameliorating renal damage and podocyte injury. J Nat Med. 2016 Oct;70(4):740–748.
   PubMed Web of Science ®Google Scholar
• Deng D, Yan N. GLUT, SGLT, and SWEET: structural and mechanistic investigations of the glucose transporters. Protein Sci. 2016 Mar;25(3):546–558.
   PubMed Web of Science ®Google Scholar
• Jurcovicova J. Glucose transport in brain - effect of inflammation. Endocr Regul. 2014 Jan;48(1):35–48.
   PubMedGoogle Scholar
• Ryniawec JM, Coope MR, Loertscher E, et al. GLUT3/SLC2A3 is an endogenous marker of hypoxia in prostate cancer cell lines and patient-derived xenograft tumors. Diagnostics. (Basel, Switzerland). 2022 Mar 10; 12(3):676. DOI:10.3390/diagnostics12030676.
   Web of Science ®Google Scholar
• Yang L, Li C, Qin Y, et al. A novel prognostic model based on ferroptosis-related gene signature for bladder cancer. Front Oncol. 2021;11:686044.
   PubMedGoogle Scholar
• Chai YJ, Yi JW, Oh SW, et al. Upregulation of SLC2 (GLUT) family genes is related to poor survival outcomes in papillary thyroid carcinoma: analysis of data from the Cancer Genome Atlas. Surgery. 2017 Jan;161(1):188–194.
   PubMed Web of Science ®Google Scholar
• Kim E, Jung S, Park WS, et al. Upregulation of SLC2A3 gene and prognosis in colorectal carcinoma: analysis of TCGA data. BMC Cancer. 2019 Apr 3;19(1):302.
   PubMedGoogle Scholar
• Yao X, He Z, Qin C, et al. SLC2A3 promotes macrophage infiltration by glycolysis reprogramming in gastric cancer. Cancer Cell Int. 2020;20:503.
   PubMed Web of Science ®Google Scholar
• Newman AM, Liu CL, Green MR, et al. Robust enumeration of cell subsets from tissue expression profiles. Nat Methods. 2015 May;12(5):453–457.
   PubMed Web of Science ®Google Scholar
• Huber MA, Azoitei N, Baumann B, et al. NF-kappaB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression. J Clin Invest. 2004 Aug;114(4):569–581.
   PubMed Web of Science ®Google Scholar
• Taniguchi K, Karin M. NF-kappaB, inflammation, immunity and cancer: coming of age. Nat Rev Immunol. 2018 May;18(5):309–324.
   PubMed Web of Science ®Google Scholar
• Lin L, Que R, Wang J, et al. Prognostic value of the ferroptosis-related gene SLC2A3 in gastric cancer and related immune mechanisms. Front Genet. 2022;13:919313.
   PubMed Web of Science ®Google Scholar
• Wang Y, He M, Zhang G, et al. The immune landscape during the tumorigenesis of cervical cancer. Cancer Med. 2021 Apr;10(7):2380–2395.
   PubMed Web of Science ®Google Scholar
• Kostic AD, Chun E, Robertson L, et al. Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. Cell Host Microbe. 2013 Aug 14;14(2):207–215.
   PubMed Web of Science ®Google Scholar
• Kim W, Chu TH, Nienhuser H, et al. PD-1 signaling promotes tumor-infiltrating myeloid-derived suppressor cells and gastric tumorigenesis in mice. Gastroenterology. 2021 Feb;160(3):781–796.
   PubMed Web of Science ®Google Scholar
• Gentles AJ, Newman AM, Liu CL, et al. The prognostic landscape of genes and infiltrating immune cells across human cancers. Nat Med. 2015 Aug;21(8):938–945.
   PubMed Web of Science ®Google Scholar
• Leemans CR, Snijders PJF, Brakenhoff RH. The molecular landscape of head and neck cancer. Nat Rev Cancer. 2018 May;18(5):269–282.
   PubMed Web of Science ®Google Scholar
• Deng D, Sun P, Yan C, et al. Molecular basis of ligand recognition and transport by glucose transporters. Nature. 2015 Oct 15;526(7573):391–396.
   PubMed Web of Science ®Google Scholar
• Dai W, Xu Y, Mo S, et al. GLUT3 induced by AMPK/CREB1 axis is key for withstanding energy stress and augments the efficacy of current colorectal cancer therapies. Signal transduction and targeted therapy. 2020 Sep 2;5(1):177. DOI:10.1038/s41392-020-00220-9.
   Google Scholar
• Schlosser HA, Drebber U, Urbanski A, et al. Glucose transporters 1, 3, 6, and 10 are expressed in gastric cancer and glucose transporter 3 is associated with UICC stage and survival. Gastric Cancer. 2017 Jan;20(1):83–91.
   PubMed Web of Science ®Google Scholar
• Tsai TH, Yang CC, Kou TC, et al. Overexpression of GLUT3 promotes metastasis of triple-negative breast cancer by modulating the inflammatory tumor microenvironment. J Cell Physiol. 2021 Jun;236(6):4669–4680.
   PubMed Web of Science ®Google Scholar
• Masin M, Vazquez J, Rossi S, et al. GLUT3 is induced during epithelial-mesenchymal transition and promotes tumor cell proliferation in non-small cell lung cancer. Cancer & Metabolism. 2014;2:11.
   PubMedGoogle Scholar
• Liang H, Bourdon AK, Chen LY, et al. Gibbs free-energy gradient along the path of glucose transport through human glucose transporter 3. ACS Chem Neurosci. 2018 Nov 21;9(11):2815–2823.
   PubMed Web of Science ®Google Scholar
• Chen D, Wang H, Chen J, et al. MicroRNA-129-5p regulates glycolysis and cell proliferation by targeting the glucose transporter SLC2A3 in gastric cancer cells. Front Pharmacol. 2018;9:502.
   PubMed Web of Science ®Google Scholar
• Martinez-Terroba E, Behrens C, de Miguel FJ, et al. A novel protein-based prognostic signature improves risk stratification to guide clinical management in early-stage lung adenocarcinoma patients. J Pathol. 2018 Aug;245(4):421–432.
   PubMed Web of Science ®Google Scholar
• Younes M, Brown RW, Stephenson M, et al. Overexpression of Glut1 and Glut3 in stage I nonsmall cell lung carcinoma is associated with poor survival. Cancer. 1997 Sep 15;80(6):1046–1051.
   PubMed Web of Science ®Google Scholar
• Zuo J, Wen J, Lei M, et al. Hypoxia promotes the invasion and metastasis of laryngeal cancer cells via EMT. Medical oncology. (Northwood, London, England): Medical Oncology; 2016. Feb; 33(2): p. 15.
   Google Scholar
• Baer S, Casaubon L, Schwartz MR, et al. Glut3 expression in biopsy specimens of laryngeal carcinoma is associated with poor survival. Laryngoscope. 2002 Feb;112(2):393–396.
   PubMed Web of Science ®Google Scholar
• Nilchian A, Giotopoulou N, Sun W, et al. Different regulation of glut1 expression and glucose uptake during the induction and chronic stages of TGFβ1-induced EMT in breast cancer cells. Biomolecules. 2020 Dec 1;10(12):1621.
   PubMed Web of Science ®Google Scholar
• Wang Y, Li Y, Jiang L, et al. Prognostic value of glycolysis markers in head and neck squamous cell carcinoma: a meta-analysis. Aging. 2021 Feb 26;13(5):7284–7299.
   PubMedGoogle Scholar
• Voelxen NF, Blatt S, Knopf P, et al. Comparative metabolic analysis in head and neck cancer and the normal gingiva. Clin Oral Investig. 2018 Mar;22(2):1033–1043.
   PubMed Web of Science ®Google Scholar
• Botha H, Farah CS, Koo K, et al. The role of glucose transporters in oral squamous cell carcinoma. Biomolecules. 2021 Jul 21;11(8). doi :10.3390/biom11081070.
   PubMed Web of Science ®Google Scholar
• Liu Y, Li YM, Tian RF, et al. The expression and significance of HIF-1alpha and GLUT-3 in glioma. Brain Res. 2009 Dec 22;1304:149–154.
   PubMed Web of Science ®Google Scholar
• Koutsioumpa M, Hatziapostolou M, Polytarchou C, et al. Lysine methyltransferase 2D regulates pancreatic carcinogenesis through metabolic reprogramming. Gut. 2019 Jul;68(7):1271–1286.
   PubMed Web of Science ®Google Scholar
• Ceballos J, Schwalfenberg M, Karageorgis G, et al. Synthesis of indomorphan pseudo-natural product inhibitors of glucose transporters GLUT-1 and -3. Angew Chem (Int Ed in English). 2019 Nov 18;58(47):17016–17025.
   PubMed Web of Science ®Google Scholar
• Klip A, McGraw TE, James DE. Thirty sweet years of GLUT4. J Biol Chem. 2019 Jul 26;294(30):11369–11381.
   PubMed Web of Science ®Google Scholar
• Matsuzu K, Segade F, Wong M, et al. Glucose transporters in the thyroid. Thyroid: Offic J Am Thyroid Association. 2005 Jun;15(6):545–550.
   PubMed Web of Science ®Google Scholar
• Dasgupta S, Rai RC. PPAR-gamma and Akt regulate GLUT1 and GLUT3 surface localization during Mycobacterium tuberculosis infection. Mol Cell Biochem. 2018 Mar;440(1–2):127–138.
   PubMed Web of Science ®Google Scholar
• Ni Y, Zhou Y, Zhou M, et al. Akt and cAMP response element binding protein mediate 17beta-estradiol regulation of glucose transporter 3 expression in human SH-SY5Y neuroblastoma cell line. Neurosci Lett. 2015 Sep 14;604:58–63.
   PubMed Web of Science ®Google Scholar
• Onodera Y, Nam JM, Bissell MJ. Increased sugar uptake promotes oncogenesis via EPAC/RAP1 and O-GlcNAc pathways. J Clin Invest. 2014 Jan;124(1):367–384.
   PubMed Web of Science ®Google Scholar
• Libby CJ, Gc S, Benavides GA, et al. A role for GLUT3 in glioblastoma cell invasion that is not recapitulated by GLUT1. Cell Adh Migr. 2021 Dec;15(1):101–115.
   PubMed Web of Science ®Google Scholar
• Sullivan WJ, Mullen PJ, Schmid EW, et al. Extracellular matrix remodeling regulates glucose metabolism through TXNIP destabilization. Cell. 2018 Sep 20;175(1):117–132 e21.
   PubMed Web of Science ®Google Scholar
• Gao H, Liang J, Duan J, et al. A prognosis marker SLC2A3 correlates with EMT and immune signature in colorectal cancer. Front Oncol. 2021;11:638099.
   PubMedGoogle Scholar
• Li H, Chen A, Yuan Q, et al. NF-kappaB/twist axis is involved in chysin inhibition of ovarian cancer stem cell features induced by co-treatment of TNF-alpha and TGF-beta. Int J Clin Exp Pathol. 2019;12(1):101–112.
   PubMed Web of Science ®Google Scholar
• Li CW, Xia W, Huo L, et al. Epithelial-mesenchymal transition induced by TNF-alpha requires NF-kappaB-mediated transcriptional upregulation of Twist1. Cancer Res. 2012 Mar 1;72(5):1290–1300.
   PubMed Web of Science ®Google Scholar
• Wu Y, Deng J, Rychahou PG, et al. Stabilization of snail by NF-kappaB is required for inflammation-induced cell migration and invasion. Cancer Cell. 2009 May 5;15(5):416–428.
   PubMed Web of Science ®Google Scholar
• Chua HL, Bhat-Nakshatri P, Clare SE, et al. NF-kappaB represses E-cadherin expression and enhances epithelial to mesenchymal transition of mammary epithelial cells: potential involvement of ZEB-1 and ZEB-2. Oncogene. 2007 Feb 1;26(5):711–724.
   PubMed Web of Science ®Google Scholar
• Tan L, Cheng D, Wen J, et al. Identification of prognostic hypoxia-related genes signature on the tumor microenvironment in esophageal cancer. Math Biosci Eng. 2021 Sep 7;18(6):7743–7758.
   PubMed Web of Science ®Google Scholar
• Zhang L, Wang S, Wang Y, et al. Effects of hypoxia in intestinal tumors on immune cell behavior in the tumor microenvironment. Front Immunol. 2021;12:645320.
   PubMed Web of Science ®Google Scholar
• He X, Ding J, Cheng X, et al. Hypoxia-related gene-based signature can evaluate the tumor immune microenvironment and predict the prognosis of colon adenocarcinoma patients. Int J Gen Med. 2021;14:9853–9862.
   PubMed Web of Science ®Google Scholar
• Lauer V, Grampp S, Platt J, et al. Hypoxia drives glucose transporter 3 expression through hypoxia-inducible transcription factor (HIF)-mediated induction of the long noncoding RNA NICI. J Biol Chem. 2020 Mar 27;295(13):4065–4078.
   PubMed Web of Science ®Google Scholar
• Han Y, Wang X, Xia K, et al. A novel defined hypoxia-related gene signature to predict the prognosis of oral squamous cell carcinoma. Ann Transl Med. 2021 Oct;9(20):1565.
   PubMed Web of Science ®Google Scholar
• Xia H, Chen J, Gao H, et al. Hypoxia-induced modulation of glucose transporter expression impacts (18)F-fluorodeoxyglucose PET-CT imaging in hepatocellular carcinoma. Eur J Nucl Med Mol Imaging. 2020 Apr;47(4):787–797.
   PubMed Web of Science ®Google Scholar
• Osumi H, Horiguchi H, Kadomatsu T, et al. Tumor cell-derived angiopoietin-like protein 2 establishes a preference for glycolytic metabolism in lung cancer cells. Cancer Sci. 2020 Apr;111(4):1241–1253.
   PubMed Web of Science ®Google Scholar
• Lu W, Wu Y, Huang S, et al. A ferroptosis-related gene signature for predicting the prognosis and drug sensitivity of head and neck squamous cell carcinoma. Front Genet. 2021;12:755486.
   PubMed Web of Science ®Google Scholar
• Wu B, Tao L, Yang D, et al. Development of an immune infiltration-related eight-gene prognostic signature in colorectal cancer microenvironment. Bio Med Res Int. 2020;2020:2719739.
   Google Scholar
• Caruntu A, Moraru L, Lupu M, et al. Prognostic potential of tumor-infiltrating immune cells in resectable oral squamous cell carcinoma. Cancers (Basel). 2021 May 8;13(9). doi :10.3390/cancers13092268.
   Web of Science ®Google Scholar
• White LG, Goy HE, Rose AJ, et al. Controlling cell trafficking: addressing failures in CAR T and NK cell therapy of solid tumours. Cancers (Basel). 2022 Feb 15;14(4). doi :10.3390/cancers14040978.
   Web of Science ®Google Scholar
• Nagarsheth N, Wicha MS, Zou W. Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy. Nat Rev Immunol. 2017 Sep;17(9):559–572.
   PubMed Web of Science ®Google Scholar